FDCDDQ
ITCI

Federation des caisses Desjardins du Quebec’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-305
Closed -$40.2K – 2861
2025
Q1 		$40.2K Hold
305
– – ﹤0.01% 1528
2024
Q4 		$25.5K Hold
305
– – ﹤0.01% 1601
2024
Q3 		$22.3K Hold
305
– – ﹤0.01% 1633
2024
Q2 		$20.9K Hold
305
– – ﹤0.01% 1609
2024
Q1 		$21.1K Hold
305
– – ﹤0.01% 1624
2023
Q4 		$21.8K Hold
305
– – ﹤0.01% 1552
2023
Q3 		$15.9K Hold
305
– – ﹤0.01% 1642
2023
Q2 		$19.3K Hold
305
– – ﹤0.01% 1585
2023
Q1 		$16.5K Hold
305
– – ﹤0.01% 1628
2022
Q4 		$16.1K Hold
305
– – ﹤0.01% 1747
2022
Q3 		$14.2K Hold
305
– – ﹤0.01% 1827
2022
Q2 		$17.4K Hold
305
– – ﹤0.01% 1806
2022
Q1 		$18.7K Hold
305
– – ﹤0.01% 1846
2021
Q4 		$16K Hold
305
– – ﹤0.01% 1904
2021
Q3 		$11.4K Hold
305
– – ﹤0.01% 2016
2021
Q2 		$12.4K Hold
305
– – ﹤0.01% 2001
2021
Q1 		$10.3K Hold
305
– – ﹤0.01% 1992
2020
Q4 		$9.7K Buy
+305
New +$8.02K ﹤0.01% 1918

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's ITCI Position: Q2 2025 in Review

Federation des caisses Desjardins du Quebec sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 305 shares — an estimated $40.2K sold.

Federation des caisses Desjardins du Quebec first reported a position in ITCI in Q4 2020 and held it in 18 quarters. The position peaked at $40.2K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • Federation des caisses Desjardins du Quebec reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 305 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $40.2K.
  • Federation des caisses Desjardins du Quebec first reported a position in Intra-Cellular Therapies Inc. in Q4 2020 and held it in 18 quarters.
  • Federation des caisses Desjardins du Quebec's Intra-Cellular Therapies Inc. position peaked at $40.2K in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2025, filed 14 Aug 2025.